We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




DNA-Spotted Microarray Developed to Detect Bioterror Pathogens

By LabMedica International staff writers
Posted on 03 Sep 2008
Lethal diseases frequently spread faster than it takes to diagnose them in the laboratory. More...
To correct that, researchers have developed a test to bring that time from days down to hours.

Dr. Sanjeev Narayanan, assistant professor, and Dr. Greg Peterson, research microbiologist, both from the department of diagnostic medicine and path biology at Kansas State University (Manhattan, KS, USA), are using a device called a DNA-spotted microarray to pinpoint the specific genetic markers that distinguish one pathogen apart from another and determine antibiotic resistance.

Traditionally, it takes days and multiple lab workers to screen a sample of soil, water, or feces for just one pathogen. Additional time is then needed to look for resistance to antibiotics. The new test developed at Kansas State simultaneously looks for multiple diseases and antibiotic resistance, reducing the time it takes from sampling to diagnosis to about 24 hours. "We needed a mass, high through-put system,” Dr. Narayanan noted. "The longer a serious disease goes undiagnosed, the harder it is to treat, and the further it can spread.”

The researchers analyzed DNA of hundreds of pathogens and synthesized DNA probes for the specific genetic sequences that set each pathogen apart. Up to now, they can detect as many as 557 genes, making it possible for them to screen for 40 different species of bacteria, 1,200 serotypes of Salmonella, five common serotypes of Escherichia coli, and resistance to the 45 most common antibiotics used to treat human and animal illnesses caused by these pathogens.

When a sample is submitted, technicians extract and fluorescently label total DNA, and run a microarray to find out whether a particular gene is present. According to Dr. Narayanan, the next phase will be to develop a test that indicates how much of a pathogen is present.

Dr. Narayanan commented that he and Dr. Peterson developed the test because most human and animal infections are caused by a combination of pathogens. Under the current practice, it can take days to isolate and identify each individual pathogen and generate their antimicrobial resistance profiles. This means physicians and veterinarians often initiate antibiotic treatment before knowing precisely what the actual problem is.

"This new test will eliminate a lot of the guesswork,” Dr. Narayanan said. It will inform the doctor how many different kinds of pathogens are in a sample and which antibiotics would not work, all in a shorter time frame. The test's efficiencies also translate into lower cost, he reported.

Should the United States ever be attacked with biologic weapons the new test also would help in quickly identifying all of the bacterial pathogens used. "Being able to get such quick results for so many pathogens at once will become critical in case of bioterrorism,” Dr. Narayanan said. "Under that scenario, every minute counts in providing treatment or preventing disease spread.” Moreover, such pathogens would likely be engineered for resistance to common drug treatment, and the new test would determine such resistance rapidly, Dr. Narayanan reported.

The test is currently being used in research labs at Kansas State's College of veterinary medicine to detect animal and zoonotic pathogens; zoonotic pathogens can be transmitted between humans and animals. The test also is being used to track the flow of genetic elements in food production systems, such as feedlots. However, Dr. Narayanan hopes the test could soon be used to enhance the clinical diagnosis of animal and human infections.

Related Links:
Kansas State University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Illustration of CNF-sheet-mediated membrane fusion between an extracellular vesicle and a lipid nanoparticle carrying molecular beacons for internal microRNA detection. (Image Credit: Kawaguchi et al., Cell Reports Physical Science, 2026. DOI: 10.1016/j.xcrp.2026.103613)

Single-Vesicle Analysis Reveals Tissue-Associated Inflammatory Signatures

Chronic inflammation can persist for months or years when immune cells continue attacking tissues despite the absence of an active threat. It is associated with cancers, brain disorders, autoimmune diseases,... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Tumor Profiling Uncovers Overlooked Hereditary Cancer Risk Genes

Patients with solid tumors often undergo molecular profiling to identify alterations that can guide therapy. This testing may also reveal constitutional cancer-predisposing DNA variants, which are present... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: Study design and collection of lower respiratory tract lining fluid (RTLF) using the PExA instrument. (Aguilera K, Hober A, Greilert Norin N, et al. eBioMedicine, 2026. doi:10.1016/j.ebiom.2026.106538)

Exhaled Breath Particles Reveal Virus-Specific Antibodies in the Lower Airways

Respiratory viruses such as influenza virus, SARS-CoV-2, and respiratory syncytial virus (RSV) require immune protection across the airway mucosa. Antibodies in the respiratory tract lining are important... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: Siemens Healthineers has begun carving out its in vitro diagnostics business as a standalone company named Olyrian Diagnostics (Photo courtesy of Siemens Healthineers)

Siemens Healthineers Begins Transition Toward Standalone Olyrian Diagnostics Business

Siemens Healthineers has begun carving out its in vitro diagnostics business, which will operate as Olyrian Diagnostics. The new name will be introduced in stages as the business prepares to become a standalone... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.